Skip to main content
Caplight Logo









Palobiofarma S.L.

Palobiofarma S.L.

Private
MataróHealthcare & Life Scienceshttps://www.palobiofarma.com/

Last Round

Series C

Feb 2, 2024

Total Funding Raised

$9.62M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Palobiofarma S.L. is a biopharmaceutical company that discovers and develops innovative drugs based on the modulation of adenosine receptors for the treatment of cancer and rare diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticalsmall-molecule drugsdrug discoveryclinical-stageadenosine receptorsbiotechdrug licensingclinical trialsoncologyrespiratory diseasesdrug pipelinemedicinal chemistrypharmaceutical R&Dpreclinical developmentmilestone payments

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Palobiofarma S.L. Comparables

Compare Palobiofarma S.L. with similar companies based on industry and business-model similarity.

Palobiofarma S.L. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Innolake Biopharm
80%
Kainova Therapeutics
79%
AlphaTON Capital Corp.
79%

Palobiofarma S.L. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CFeb 2, 2024
Series BSep 26, 2019
VC RoundJun 20, 2013
VC RoundMay 1, 2012
SeedJun 28, 2010

Key People

Founding team and executive leadership

Santiago Figueroa Perez

Chief Operating Officer

Executive Team

Palobiofarma S.L. Investors

Notable investors and investment history

Palobiofarma S.L. investors
InvestorRounds
Foundation for Prader-Willi ResearchSeries C
InvereadySeries C
FitalentVC Round
SodenaVC Round, Series C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 22, 2026

    Monthly visitors increased 31% MoM.

  • Apr 22, 2026

    Monthly visitors increased 106% MoM.

Palobiofarma S.L. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Palobiofarma S.L. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Palobiofarma S.L.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersMataró
Employee Range21
Year Founded2006
Last FundingFeb 2, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?